Key statistics
As of last trade GE Healthcare Technologies Inc (L0T:FRA) traded at 70.04, -17.09% below its 52-week high of 84.48, set on Feb 28, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 70.10 |
|---|---|
| High | 70.72 |
| Low | 70.00 |
| Bid | 70.06 |
| Offer | 71.40 |
| Previous close | 71.00 |
| Average volume | 217.86 |
|---|---|
| Shares outstanding | 455.75m |
| Free float | 453.47m |
| P/E (TTM) | 18.51 |
| Market cap | 38.41bn USD |
| EPS (TTM) | 4.55 USD |
| Annual div (ADY) | 0.1185 EUR |
|---|---|
| Annual div yield (ADY) | 0.17% |
| Div ex-date | Jan 09 2026 |
| Div pay-date | Feb 13 2026 |
| Next div ex-date | Apr 02 2026 |
| Next div pay-date | May 15 2026 |
Data delayed at least 15 minutes, as of Mar 02 2026 12:05 GMT.
More ▼
Press releases
- GE HealthCare achieves MRI portfolio milestone with FDA clearances for next-generation SIGNA MRI technology designed to enhance precision imaging and clinical efficiency
- GE HealthCare builds on BARDA collaboration with approximately $35 million expansion to advance artificial intelligence-powered ultrasound for trauma care and emergency preparedness
- GE HealthCare announces cash dividend for first quarter of 2026
- GE HealthCare management to present at upcoming investor conferences
- GE HealthCare launches ReadyFix fleet management solution to help enhance operational efficiency and reliable patient care
- GE HealthCare reports fourth quarter and full year 2025 financial results
- GE HealthCare announces U.S. FDA 510(k) clearance and CE Mark for Allia Moveo and marks first global installation, advancing precision care in the interventional suite
- GE HealthCare Recommends Shareholders Reject “Mini-Tender” Offer by Potemkin Limited
- GE HealthCare to announce fourth quarter and full year 2025 results on February 4, 2026
- GE HealthCare management to present at upcoming investor conference
More ▼
